Published in World J Gastroenterol on May 14, 2007
Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach. World J Gastroenterol (2013) 0.82
Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). Eur J Hum Genet (2014) 0.81
TERT promoter mutations are a rare event in gastrointestinal stromal tumors. Springerplus (2015) 0.75
Gastrointestinal stromal tumors (GIST): facing cell death between autophagy and apoptosis. Autophagy (2017) 0.75
Clinicopathological and molecular characteristics of synchronous gastric adenocarcinoma and gastrointestinal stromal tumors. Sci Rep (2017) 0.75
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol (1992) 34.17
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol (1983) 4.35
Telomerase activity and patient survival after surgery for gastric and oesophageal cancer. Eur J Gastroenterol Hepatol (2001) 1.49
Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med (2000) 1.49
Clinical implications of telomerase in cancer. Eur J Cancer (1997) 1.34
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J (1996) 1.23
Bcl-2 modulates telomerase activity. J Biol Chem (1997) 1.22
Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development. Am J Pathol (1995) 1.21
Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci (2003) 1.18
Prognostic assessment of gastrointestinal stromal tumor. Am J Clin Oncol (2003) 1.05
Telomeres and telomerase: biological and clinical importance. Clin Chem (1997) 1.03
Life and cancer without telomerase. Cell (1997) 0.92
Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients. Eur J Gastroenterol Hepatol (2003) 0.90
Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer. Obstet Gynecol (1998) 0.87
Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status. Clin Cancer Res (1998) 0.82